Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
ASSETS
Cash and due from banks		$ 468,426	$ 397,848
Interest-bearing funds with Federal Reserve Bank		641,476	460,928
Interest earning deposits with banks		19,841	26,311
Federal funds sold and securities purchased under resale agreements		13,821	47,846
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	[1],[2]	1,143,564	932,933
Mortgage loans held for sale, at fair value		37,129	48,024
Investment securities available for sale, at fair value		3,991,632	3,987,069
Loans, net of deferred fees and costs		25,946,573	24,787,464
Allowance for loan losses		(250,555)	(249,268)
Loans, net		25,696,018	24,538,196
Cash surrender value of bank-owned life insurance		554,134	540,958
Premises and equipment, net		434,307	426,813
Goodwill		57,315	57,315
Other intangible assets		9,875	11,254
Deferred tax asset, net		141,134	165,788
Other assets		604,084	513,487
Total assets		32,669,192	31,221,837
Liabilities
Non-interest-bearing deposits		7,650,967	7,686,339
Interest-bearing deposits		19,069,355	18,461,561
Total deposits		26,720,322	26,147,900
Federal funds purchased and securities sold under repurchase agreements		237,692	161,190
Other short-term borrowings		650,000	100,000
Long-term debt		1,657,157	1,606,138
Other liabilities		270,419	245,043
Total liabilities		29,535,590	28,260,271
Shareholders' Equity
Common stock - $1.00 par value; authorized 342,857,143 shares; 143,300,449 issued at December 31, 2018 and 142,677,449 issued at December 31, 2017; 115,865,510 outstanding at December 31, 2018 and 118,897,295 outstanding at December 31, 2017		143,300	142,678
Additional paid-in capital		3,060,561	3,043,129
Treasury stock, at cost – 27,434,939 shares at December 31, 2018 and 23,780,154 shares at December 31, 2017		(1,014,746)	(839,674)
Accumulated other comprehensive loss, net		(94,420)	(54,754)
Retained earnings		843,767	544,207
Total shareholders’ equity		3,133,602	2,961,566
Total liabilities and shareholders' equity		32,669,192	31,221,837
Series C Preferred Stock
Shareholders' Equity
Preferred Stock		0	125,980
Series D Preferred Stock
Shareholders' Equity
Preferred Stock		$ 195,140	$ 0

[1] See "Note 1 - Summary of Significant Accounting Policies" of this Report for information on Synovus' change in presentation of cash and cash equivalents.

[2] See "Note 1 - Summary of Significant Accounting Policies" of this Report for information on Synovus' change in presentation of cash and cash equivalents.See accompanying notes to the audited consolidated financial statements.